BioNTech (BNTX) PT Lowered to $195 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $116.57 +5.12%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on BioNTech (NASDAQ: BNTX) to $195.00 (from $197.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
